Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
A "vicious and scheming" killer murdered her boyfriend then tried to recruit a local butcher to help her dispose of his body has been jailed
A look ahead at the forecast for the Tyne Tees region.
Doctors across the North East are warning of a shortage in GP numbers